TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE2646.2510.35 (+0.39 %)
PREV CLOSE ( ) 2635.90
OPEN PRICE ( ) 2636.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5548
TODAY'S LOW / HIGH ( )2604.35 2656.25
52 WK LOW / HIGH ( )1619 3040
NSE2648.1512.9 (+0.49 %)
PREV CLOSE( ) 2635.25
OPEN PRICE ( ) 2640.90
BID PRICE (QTY) 2648.15 (252)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 443542
TODAY'S LOW / HIGH( ) 2602.50 2657.30
52 WK LOW / HIGH ( )1583.25 3031.2
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 15-07 1972
Management Info
Samir Mehta - Chairman - Managing Director
Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
19Jan Torrent Pharmaceuticals informs about
Pursuant to Regulation 42 of Listing Regulations, Torrent Pharmaceutical..
18Jan Corporate Action-Board to consider Di
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed..
01Jan Announcement under Regulation 30 (LOD
As per Regulation 30 of SEBI (Listing Obligations and Disclosure Require..
17Dec Intimation Regarding Issue Of Commerc
Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and..
16Dec Torrent Pharmaceuticals raises Rs 100
Torrent Pharmaceuticals has raised Rs 100 crore through Commercial Paper..
Financials
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit28309390
Gross Profit 3560 11170
Operating Profit 595021540
Net Sales 1640061680
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 3754.85 (4.43%)
M.Cap (Rs. in Cr)9387.13
Procter&Gamble Healt (BSE)
 7178.50 (1.21%)
M.Cap (Rs. in Cr)11915.87
Jubilant LifeScience (BSE)
 927.20 (4.36%)
M.Cap (Rs. in Cr)14768.55
NGL Fine-Chem (BSE)
 1244.70 (3.17%)
M.Cap (Rs. in Cr)768.98
IOL Chem & Pharma (BSE)
 709.95 (3.55%)
M.Cap (Rs. in Cr)4167.80
Shareholding Pattern
PROMOTERS 71.25%
NON-INSTITUTION 8.7%
MUTUAL FUNDS/UTI 6.9%
FI/BANKS/INSURANCE 0.04%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.